PriceTargets.com logo

Equifax - EFX Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $277.13
  • Forecasted Upside: 31.17%
  • Number of Analysts: 21
  • Breakdown:
  • 0 Sell Ratings
  • 8 Hold Ratings
  • 12 Buy Ratings
  • 1 Strong Buy Ratings
$211.27 As of 12/4/2025 04:59 PM ET
▲ +1.52 (0.72%)

This chart shows the closing price for EFX by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Equifax Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for EFX and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for EFX

Analyst Price Target is $277.13
▲ +31.17% Upside Potential
This price target is based on 21 analysts offering 12 month price targets for Equifax in the last 3 months. The average price target is $277.13, with a high forecast of $305.00 and a low forecast of $240.00. The average price target represents a 31.17% upside from the last price of $211.27.

This chart shows the closing price for EFX for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 21 investment analysts is to moderate buy stock in Equifax. This Moderate Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 14 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
6/12/2024
  • 1 strong buy ratings
  • 13 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
9/10/2024
  • 0 strong buy ratings
  • 14 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
12/9/2024
  • 1 strong buy ratings
  • 14 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
3/9/2025
  • 1 strong buy ratings
  • 13 buy ratings
  • 5 hold ratings
  • 0 sell ratings
Ratings as of
6/7/2025
  • 1 strong buy ratings
  • 12 buy ratings
  • 6 hold ratings
  • 0 sell ratings
Ratings as of
9/5/2025
  • 1 strong buy ratings
  • 12 buy ratings
  • 8 hold ratings
  • 0 sell ratings
Ratings as of
11/4/2025
  • 1 strong buy ratings
  • 12 buy ratings
  • 8 hold ratings
  • 0 sell ratings
Ratings as of
12/4/2025

Latest Recommendations

  • 1 strong buy ratings
  • 12 buy ratings
  • 8 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
12/1/2025Weiss RatingsReiterated RatingHold (C) ➝ Hold (C)
11/25/2025Weiss RatingsReiterated RatingHold (C) ➝ Hold (C)
11/19/2025Weiss RatingsReiterated RatingHold (C) ➝ Hold (C)
11/13/2025Weiss RatingsReiterated RatingHold (C) ➝ Hold (C)
10/22/2025Stifel NicolausLower TargetBuy ➝ Buy$295.00 ➝ $253.00
10/22/2025BMO Capital MarketsLower TargetMarket Perform ➝ Market Perform$251.00 ➝ $245.00
10/21/2025Needham & Company LLCReiterated RatingBuy ➝ Buy$295.00
10/15/2025Wells Fargo & CompanyLower TargetOverweight ➝ Overweight$300.00 ➝ $285.00
10/13/2025OppenheimerInitiated CoverageOutperform$279.00 ➝ $271.00
10/8/2025Weiss RatingsReiterated RatingHold (C+) ➝ Hold (C+)
10/8/2025Needham & Company LLCReiterated RatingBuy ➝ Buy$295.00
10/3/2025Morgan StanleyReiterated RatingOverweight ➝ Overweight
10/3/2025Bank of AmericaLower TargetNeutral ➝ Neutral$285.00 ➝ $250.00
10/1/2025Seaport Res PtnUpgradeHold
9/27/2025Weiss RatingsReiterated RatingHold (C+) ➝ Hold (C+)
9/15/2025UBS GroupBoost TargetBuy ➝ Buy$287.00 ➝ $297.00
7/23/2025UBS GroupLower TargetBuy ➝ Buy$315.00 ➝ $278.00
7/23/2025CitigroupLower TargetBuy ➝ Buy$294.00 ➝ $290.00
7/23/2025BMO Capital MarketsLower TargetMarket Perform ➝ Market Perform$280.00 ➝ $260.00
7/23/2025OppenheimerLower TargetOutperform ➝ Outperform$296.00 ➝ $279.00
7/23/2025JPMorgan Chase & Co.Lower TargetOverweight ➝ Overweight$277.00 ➝ $272.00
7/23/2025Wells Fargo & CompanyLower TargetOverweight ➝ Overweight$310.00 ➝ $300.00
7/23/2025Robert W. BairdLower TargetOutperform ➝ Outperform$310.00 ➝ $289.00
7/23/2025BarclaysLower TargetEqual Weight ➝ Equal Weight$260.00 ➝ $240.00
7/10/2025BMO Capital MarketsInitiated CoverageMarket Perform$280.00
7/7/2025Wells Fargo & CompanyBoost TargetOverweight ➝ Overweight$306.00 ➝ $310.00
6/23/2025Bank of AmericaDowngradeBuy ➝ Neutral$300.00 ➝ $285.00
6/20/2025Needham & Company LLCReiterated RatingBuy ➝ Buy$295.00
6/18/2025Stifel NicolausBoost TargetBuy ➝ Buy$277.00 ➝ $295.00
6/18/2025Royal Bank Of CanadaReiterated RatingOutperform ➝ Outperform$300.00
6/10/2025Morgan StanleyReiterated RatingOverweight ➝ Overweight$295.00 ➝ $305.00
5/22/2025OppenheimerBoost TargetOutperform ➝ Outperform$277.00 ➝ $296.00
5/21/2025Wells Fargo & CompanyBoost TargetOverweight ➝ Overweight$288.00 ➝ $306.00
4/23/2025Royal Bank Of CanadaReiterated RatingOutperform ➝ Outperform$300.00 ➝ $300.00
4/23/2025Needham & Company LLCReiterated RatingBuy ➝ Buy$295.00 ➝ $295.00
4/14/2025Wells Fargo & CompanyLower TargetOverweight ➝ Overweight$313.00 ➝ $284.00
4/10/2025Bank of AmericaInitiated CoverageBuy$280.00
4/4/2025BarclaysReiterated RatingOverweight ➝ Equal Weight$325.00 ➝ $260.00
3/20/2025Royal Bank Of CanadaUpgradeSector Perform ➝ Outperform$300.00
3/14/2025BNP ParibasDowngradeOutperform ➝ Neutral$265.00
2/18/2025Gordon HaskettUpgradeStrong-Buy
2/11/2025ArgusDowngradeBuy ➝ Hold
2/7/2025BarclaysLower TargetOverweight ➝ Overweight$335.00 ➝ $325.00
2/7/2025OppenheimerLower TargetOutperform ➝ Outperform$286.00 ➝ $279.00
2/7/2025Stifel NicolausLower TargetBuy ➝ Buy$284.00 ➝ $281.00
2/7/2025UBS GroupLower TargetBuy ➝ Buy$335.00 ➝ $310.00
2/7/2025William BlairReiterated RatingOutperform
2/7/2025Needham & Company LLCLower TargetBuy ➝ Buy$325.00 ➝ $300.00
2/3/2025Wells Fargo & CompanyLower TargetOverweight ➝ Overweight$321.00 ➝ $313.00
1/28/2025Morgan StanleyLower TargetOverweight ➝ Overweight$320.00 ➝ $316.00
1/15/2025Jefferies Financial GroupLower TargetBuy ➝ Buy$340.00 ➝ $300.00
1/10/2025Wells Fargo & CompanyLower TargetOverweight ➝ Overweight$325.00 ➝ $321.00
12/16/2024BNP ParibasUpgradeNeutral ➝ Outperform$305.00
12/12/2024Wolfe ResearchDowngradeOutperform ➝ Peer Perform
12/12/2024Morgan StanleyUpgradeEqual Weight ➝ Overweight$275.00 ➝ $320.00
11/20/2024Stifel NicolausLower TargetBuy ➝ Buy$305.00 ➝ $284.00
11/19/2024JPMorgan Chase & Co.Lower TargetOverweight ➝ Overweight$304.00 ➝ $283.00
11/19/2024OppenheimerLower TargetOutperform ➝ Outperform$315.00 ➝ $286.00
10/28/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$350.00 ➝ $350.00
10/18/2024Wells Fargo & CompanyReiterated RatingBuy ➝ Buy
10/18/2024Robert W. BairdBoost TargetOutperform ➝ Outperform$290.00 ➝ $333.00
10/18/2024JPMorgan Chase & Co.Boost TargetOverweight ➝ Overweight$300.00 ➝ $304.00
10/18/2024Wells Fargo & CompanyLower TargetOverweight ➝ Overweight$375.00 ➝ $350.00
10/18/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$350.00 ➝ $350.00
10/8/2024OppenheimerBoost TargetOutperform ➝ Outperform$300.00 ➝ $315.00
10/2/2024Wells Fargo & CompanyBoost TargetOverweight ➝ Overweight$340.00 ➝ $375.00
10/1/2024UBS GroupInitiated CoverageBuy$360.00
9/19/2024BNP ParibasUpgradeUnderperform ➝ Neutral$310.00
9/13/2024BarclaysBoost TargetOverweight ➝ Overweight$300.00 ➝ $380.00
9/12/2024Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$250.00 ➝ $271.00
8/20/2024The Goldman Sachs GroupBoost TargetNeutral ➝ Neutral$277.00 ➝ $307.00
8/13/2024Wells Fargo & CompanyUpgradeStrong-Buy
8/12/2024Wells Fargo & CompanyInitiated CoverageOverweight$340.00
7/24/2024CitigroupBoost TargetBuy ➝ Buy$263.00 ➝ $304.00
7/19/2024JPMorgan Chase & Co.Boost TargetOverweight ➝ Overweight$273.00 ➝ $300.00
7/19/2024Stifel NicolausBoost TargetBuy ➝ Buy$265.00 ➝ $305.00
7/19/2024OppenheimerBoost TargetOutperform ➝ Outperform$272.00 ➝ $300.00
7/19/2024Needham & Company LLCBoost TargetBuy ➝ Buy$305.00 ➝ $320.00
7/19/2024Robert W. BairdBoost TargetOutperform ➝ Outperform$260.00 ➝ $290.00
7/19/2024The Goldman Sachs GroupBoost TargetNeutral ➝ Neutral$246.00 ➝ $277.00
7/18/2024Bank of AmericaBoost TargetBuy ➝ Buy$255.00 ➝ $286.00
7/9/2024Wolfe ResearchInitiated CoverageOutperform$275.00
4/19/2024Bank of AmericaLower TargetBuy ➝ Buy$300.00 ➝ $255.00
4/19/2024OppenheimerLower TargetOutperform ➝ Outperform$291.00 ➝ $272.00
4/19/2024The Goldman Sachs GroupLower TargetNeutral ➝ Neutral$276.00 ➝ $241.00
4/19/2024JPMorgan Chase & Co.Lower TargetOverweight ➝ Overweight$290.00 ➝ $273.00
4/19/2024Robert W. BairdLower TargetOutperform ➝ Outperform$275.00 ➝ $260.00
4/18/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$305.00
4/9/2024OppenheimerBoost TargetOutperform ➝ Outperform$273.00 ➝ $291.00
2/13/2024Evercore ISIUpgradeIn-Line ➝ Outperform$210.00 ➝ $310.00
2/9/2024Truist FinancialBoost TargetBuy ➝ Buy$270.00 ➝ $285.00
2/9/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$305.00
1/11/2024Redburn AtlanticDowngradeBuy ➝ Neutral$272.00
1/9/2024Stifel NicolausBoost TargetBuy ➝ Buy$208.00 ➝ $289.00
1/8/2024Bank of AmericaUpgradeUnderperform ➝ Buy$164.00 ➝ $300.00
1/4/2024Needham & Company LLCBoost TargetBuy ➝ Buy$230.00 ➝ $305.00
12/29/2023The Goldman Sachs GroupBoost TargetNeutral ➝ Neutral$195.00 ➝ $222.00
12/19/2023OppenheimerInitiated CoverageOutperform$273.00
12/18/2023Jefferies Financial GroupUpgradeHold ➝ Buy$200.00 ➝ $315.00
12/15/2023Wells Fargo & CompanyUpgradeEqual Weight ➝ Overweight$200.00 ➝ $290.00
12/8/2023Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy$218.00 ➝ $267.00
12/1/2023The Goldman Sachs GroupBoost TargetNeutral ➝ Neutral$173.00 ➝ $195.00
11/20/2023CitigroupInitiated CoverageBuy$243.00
11/17/2023Royal Bank Of CanadaReiterated RatingOutperform ➝ Outperform
10/20/2023Truist FinancialLower TargetBuy ➝ Buy$250.00 ➝ $210.00
10/20/2023Wells Fargo & CompanyLower TargetEqual Weight ➝ Equal Weight$215.00 ➝ $200.00
10/20/2023Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$204.00 ➝ $196.00
10/19/2023Needham & Company LLCLower TargetBuy ➝ Buy$250.00 ➝ $230.00
10/10/2023Bank of AmericaLower Target$195.00 ➝ $175.00
10/2/2023The Goldman Sachs GroupLower TargetNeutral ➝ Neutral$232.00 ➝ $208.00
7/24/2023Bank of AmericaDowngradeNeutral ➝ Underperform$255.00 ➝ $195.00
7/21/2023JPMorgan Chase & Co.Boost TargetOverweight$238.00 ➝ $260.00
7/21/2023Morgan StanleyBoost TargetEqual Weight$190.00 ➝ $204.00
7/21/2023Credit Suisse GroupBoost TargetOutperform$235.00 ➝ $250.00
7/21/2023Robert W. BairdLower TargetOutperform$260.00 ➝ $239.00
7/18/2023Bank of AmericaBoost Target$232.00 ➝ $255.00
7/10/2023Jefferies Financial GroupBoost Target$204.00 ➝ $221.00
4/21/2023Royal Bank Of CanadaReiterated RatingSector Perform$205.00
4/21/2023Wells Fargo & CompanyBoost TargetEqual Weight$210.00 ➝ $215.00
4/21/2023Truist FinancialLower TargetBuy$260.00 ➝ $250.00
4/21/2023Deutsche Bank AktiengesellschaftLower TargetHold$214.00 ➝ $212.00
3/31/2023BarclaysLower TargetOverweight$240.00 ➝ $235.00
3/22/2023Morgan StanleyLower TargetEqual Weight$194.00 ➝ $190.00
2/10/2023Royal Bank Of CanadaBoost TargetSector Perform$185.00 ➝ $205.00
2/10/2023Morgan StanleyLower TargetEqual Weight$197.00 ➝ $194.00
2/10/2023Robert W. BairdBoost TargetOutperform$223.00 ➝ $237.00
2/10/2023BarclaysBoost TargetOverweight$230.00 ➝ $240.00
2/6/2023Truist FinancialBoost Target$195.00 ➝ $260.00
1/13/2023Wells Fargo & CompanyBoost TargetEqual Weight$165.00 ➝ $210.00
1/10/2023The Goldman Sachs GroupBoost TargetNeutral$187.00 ➝ $212.00
1/6/2023BNP ParibasInitiated CoverageUnderperform$150.00
1/4/2023Morgan StanleyBoost TargetEqual Weight$192.00 ➝ $197.00
12/20/2022Deutsche Bank AktiengesellschaftBoost Target$160.00 ➝ $175.00
12/9/2022Stifel NicolausBoost Target$181.00 ➝ $222.00
12/2/2022BarclaysBoost TargetOverweight$225.00 ➝ $230.00
11/25/2022Robert W. BairdBoost TargetOutperform$199.00 ➝ $223.00
11/18/2022JPMorgan Chase & Co.Boost TargetOverweight$196.00 ➝ $219.00
11/15/2022Atlantic SecuritiesUpgradeNeutral ➝ Overweight$230.00
11/14/2022Needham & Company LLCBoost TargetBuy$190.00 ➝ $230.00
10/21/2022Wells Fargo & CompanyLower TargetEqual Weight$200.00 ➝ $165.00
10/21/2022The Goldman Sachs GroupLower TargetNeutral$215.00 ➝ $187.00
10/21/2022Morgan StanleyLower TargetEqual Weight$212.00 ➝ $192.00
10/21/2022Robert W. BairdLower Target$211.00 ➝ $199.00
10/20/2022Royal Bank Of CanadaDowngradeOutperform ➝ Sector Perform$195.00 ➝ $158.00
10/20/2022Needham & Company LLCLower TargetBuy$250.00 ➝ $190.00
10/19/2022Jefferies Financial GroupDowngradeBuy ➝ Hold$250.00 ➝ $161.00
10/18/2022Deutsche Bank AktiengesellschaftLower TargetHold$221.00 ➝ $185.00
10/4/2022BarclaysLower TargetOverweight$230.00 ➝ $225.00
9/27/2022Morgan StanleyLower TargetEqual Weight$230.00 ➝ $212.00
9/22/2022Atlantic SecuritiesLower TargetNeutral$225.00 ➝ $200.00
8/16/2022Morgan StanleyDowngradeOverweight ➝ Equal Weight$230.00
8/15/2022Atlantic SecuritiesDowngradeOverweight ➝ Neutral$210.00 ➝ $225.00
7/22/2022Truist FinancialLower TargetBuy$250.00 ➝ $230.00
7/21/2022Credit Suisse GroupLower TargetOutperform$250.00 ➝ $245.00
7/20/2022Morgan StanleyLower TargetOverweight$227.00 ➝ $226.00
7/19/2022Deutsche Bank AktiengesellschaftLower Target$225.00 ➝ $223.00
7/12/2022Wells Fargo & CompanyInitiated CoverageEqual Weight$200.00
7/1/2022Stifel NicolausLower TargetBuy$254.00 ➝ $223.00
6/17/2022BarclaysLower TargetOverweight$250.00 ➝ $215.00
6/16/2022Morgan StanleyLower TargetOverweight$250.00 ➝ $227.00
4/22/2022Morgan StanleyLower TargetOverweight$274.00 ➝ $250.00
4/22/2022Needham & Company LLCLower TargetBuy$335.00 ➝ $275.00
4/22/2022Credit Suisse GroupLower TargetOutperform$285.00 ➝ $250.00
4/22/2022Deutsche Bank AktiengesellschaftLower TargetHold$265.00 ➝ $225.00
4/22/2022BarclaysLower TargetOverweight$300.00 ➝ $250.00
4/21/2022The Goldman Sachs GroupLower TargetNeutral ➝ Neutral$255.00 ➝ $221.00
4/21/2022Royal Bank Of CanadaLower TargetOutperform$300.00 ➝ $244.00
3/29/2022Deutsche Bank AktiengesellschaftInitiated CoverageHold$265.00
3/17/2022BarclaysLower TargetOverweight$330.00 ➝ $300.00
3/16/2022Morgan StanleyLower TargetOverweight$296.00 ➝ $274.00
3/11/2022Bank of AmericaInitiated CoverageNeutral ➝ Neutral
2/11/2022Morgan StanleyLower TargetOverweight$325.00 ➝ $296.00
1/31/2022Royal Bank Of CanadaUpgradeSector Perform ➝ Outperform$294.00 ➝ $300.00
1/27/2022Truist FinancialUpgradeHold ➝ Buy$280.00
1/24/2022Robert W. BairdUpgradeNeutral ➝ Outperform$290.00 ➝ $281.00
1/5/2022Morgan StanleyUpgradeEqual Weight ➝ Overweight$264.00 ➝ $325.00
11/22/2021Exane BNP ParibasDowngradeOutperform ➝ Neutral$296.06 ➝ $290.00
11/22/2021BNP ParibasDowngradeOutperform ➝ Neutral$290.00
11/12/2021Needham & Company LLCBoost TargetBuy$295.00 ➝ $335.00
11/11/2021Royal Bank Of CanadaBoost TargetSector Perform$270.00 ➝ $294.00
11/11/2021Morgan StanleyBoost TargetEqual Weight$255.00 ➝ $264.00
10/22/2021Morgan StanleyBoost TargetEqual Weight$253.00 ➝ $255.00
10/22/2021Truist FinancialBoost TargetHold$235.00 ➝ $245.00
10/22/2021ArgusUpgradeHold ➝ Buy$285.00
10/14/2021Evercore ISIInitiated CoverageOutperform
10/14/2021Needham & Company LLCBoost TargetMarket Perform ➝ Buy$288.00 ➝ $295.00
9/23/2021Morgan StanleyBoost TargetEqual Weight$241.00 ➝ $253.00
8/17/2021BarclaysBoost TargetOverweight$285.00 ➝ $330.00
7/28/2021BarclaysBoost TargetOverweight$270.00 ➝ $285.00
7/23/2021The Goldman Sachs GroupBoost TargetNeutral$241.00 ➝ $267.00
7/23/2021Morgan StanleyBoost TargetEqual Weight$220.00 ➝ $241.00
7/23/2021Truist FinancialBoost TargetHold$205.00 ➝ $235.00
7/22/2021Needham & Company LLCBoost TargetBuy$260.00 ➝ $288.00
7/22/2021Royal Bank Of CanadaBoost TargetNeutral ➝ Sector Perform$259.00 ➝ $270.00
7/7/2021Royal Bank Of CanadaInitiated CoverageSector Perform$259.00
4/28/2021BarclaysBoost TargetOverweight$210.00 ➝ $270.00
4/23/2021Morgan StanleyBoost TargetEqual Weight$201.00 ➝ $220.00
4/22/2021Needham & Company LLCBoost TargetBuy$215.00 ➝ $260.00
2/11/2021Needham & Company LLCBoost TargetBuy$210.00 ➝ $215.00
1/19/2021CIBCInitiated CoverageNeutral$8.50
1/6/2021Morgan StanleyBoost TargetEqual Weight$184.00 ➝ $201.00
12/15/2020Atlantic SecuritiesUpgradeNeutral ➝ Overweight$228.00
12/11/2020Stifel NicolausUpgradeHold ➝ Buy$240.00
12/8/2020Wells Fargo & CompanyBoost TargetOverweight$220.00 ➝ $230.00
12/8/2020Needham & Company LLCBoost TargetBuy$200.00 ➝ $210.00
12/8/2020BarclaysUpgradeEqual Weight ➝ Overweight$200.00 ➝ $210.00
(Data available from 12/4/2020 forward)

News Sentiment Rating

1.27 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/8/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/7/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/7/2025
  • 45 very positive mentions
  • 23 positive mentions
  • 6 negative mentions
  • 1 very negative mentions
Mentions as of
8/6/2025
  • 83 very positive mentions
  • 17 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Mentions as of
9/5/2025
  • 46 very positive mentions
  • 20 positive mentions
  • 5 negative mentions
  • 2 very negative mentions
Mentions as of
10/5/2025
  • 57 very positive mentions
  • 48 positive mentions
  • 6 negative mentions
  • 0 very negative mentions
Mentions as of
11/4/2025
  • 71 very positive mentions
  • 22 positive mentions
  • 0 negative mentions
  • 2 very negative mentions
Mentions as of
12/4/2025

Current Sentiment

  • 71 very positive mentions
  • 22 positive mentions
  • 0 negative mentions
  • 2 very negative mentions

Recent Stories by Sentiment

Very Negative

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Equifax logo
Equifax Inc. operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship. The USIS segment provides consumer and commercial information services, such as credit information and credit scoring, credit modeling and portfolio analytics, locate, fraud detection and prevention, identity verification, and other consulting services; mortgage services; financial marketing services; identity management services; and credit monitoring products. The International segment offers information service products, which include consumer and commercial services, such as credit and financial information, and credit scoring and modeling; and credit and other marketing products and services, as well as offers information, technology, and other services to support debt collections and recovery management. The company serves customers in financial services, mortgage, retail, telecommunications, utilities, automotive, brokerage, healthcare, and insurance industries, as well as government agencies. It operates in Argentina, Australia, Brazil, Canada, Chile, Costa Rica, Dominican Republic, Ecuador, El Salvador, Honduras, India, Ireland, Mexico, New Zealand, Paraguay, Peru, Portugal, Spain, the United Kingdom, Uruguay, and the United States. The company was founded in 1899 and is headquartered in Atlanta, Georgia.
Read More

Today's Range

Now: $211.27
Low: $209.92
High: $214.28

50 Day Range

MA: $221.39
Low: $204.21
High: $256.63

52 Week Range

Now: $211.27
Low: $199.98
High: $281.07

Volume

2,754,147 shs

Average Volume

1,267,311 shs

Market Capitalization

$25.86 billion

P/E Ratio

40.09

Dividend Yield

0.95%

Beta

1.59

Frequently Asked Questions

What sell-side analysts currently cover shares of Equifax?

The following sell-side analysts have issued stock ratings on Equifax in the last twelve months: Argus, Bank of America Corporation, Barclays PLC, BMO Capital Markets, BNP Paribas, Citigroup Inc., Gordon Haskett, Jefferies Financial Group Inc., JPMorgan Chase & Co., Morgan Stanley, Needham & Company LLC, Oppenheimer Holdings, Inc., Robert W. Baird, Royal Bank Of Canada, Seaport Res Ptn, Stifel Nicolaus, UBS Group AG, Weiss Ratings, Wells Fargo & Company, William Blair, and Wolfe Research.
View the latest analyst ratings for EFX.

What is the current price target for Equifax?

0 Wall Street analysts have set twelve-month price targets for Equifax in the last year. Their average twelve-month price target is $277.13, suggesting a possible upside of 31.2%. Morgan Stanley has the highest price target set, predicting EFX will reach $305.00 in the next twelve months. Barclays PLC has the lowest price target set, forecasting a price of $240.00 for Equifax in the next year.
View the latest price targets for EFX.

What is the current consensus analyst rating for Equifax?

Equifax currently has 8 hold ratings, 12 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for EFX.

What other companies compete with Equifax?

Other companies that are similar to Equifax include Cross Country Healthcare, Charles River Associates, Aptiv, Genpact and IQVIA. Learn More about companies similar to Equifax.

How do I contact Equifax's investor relations team?

Equifax's physical mailing address is 1550 PEACHTREE STREET N.W., ATLANTA GA, 30309. The credit services provider's listed phone number is (404) 885-8000 and its investor relations email address is [email protected]. The official website for Equifax is www.equifax.com. Learn More about contacing Equifax investor relations.